APA (7th ed.) Citation

Sandeep, K. S., Appachu, S., Diwaker, R. B., Vivek, S., & Simha, V. V. S. (2025). Clinical outcomes and safety study of CDK4/6 inhibitors in hormone-positive metastatic breast cancer - A real-world tertiary cancer center experience. Indian Journal of Cancer, 62(4), 541. https://doi.org/10.4103/ijc.ijc_643_23

Chicago Style (17th ed.) Citation

Sandeep, K. S., Sandhya Appachu, Ravi B. Diwaker, Sai Vivek, and Vijai V. S. Simha. "Clinical Outcomes and Safety Study of CDK4/6 Inhibitors in Hormone-positive Metastatic Breast Cancer - A Real-world Tertiary Cancer Center Experience." Indian Journal of Cancer 62, no. 4 (2025): 541. https://doi.org/10.4103/ijc.ijc_643_23.

MLA (9th ed.) Citation

Sandeep, K. S., et al. "Clinical Outcomes and Safety Study of CDK4/6 Inhibitors in Hormone-positive Metastatic Breast Cancer - A Real-world Tertiary Cancer Center Experience." Indian Journal of Cancer, vol. 62, no. 4, 2025, p. 541, https://doi.org/10.4103/ijc.ijc_643_23.